Nasdaq:US$15.62 (-0.43) | HKEX:HK$24.68 (+0.08) | AIM:£2.36 (+0.11)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Career
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Career
Announcements
Hutchmed
Shareholder Information
| Announcements
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
found Documents: 881
Announcements & Press Releases, Regulatory Notice
| 31 Mar 2008
Holding in Company
1 item
a080331
Announcements & Press Releases, Group
| 19 Mar 2008
Preliminary Results for the year ended 31 December 2007
1 item
a080319
Announcements & Press Releases, Oncology / Immunology
| 29 Feb 2008
Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb Ulcerative Colitis Clinical Trial of HMPL-004, its Leading Anti-Inflammatory Drug Candidate
1 item
a080229
Announcements & Press Releases, Regulatory Notice
| 28 Feb 2008
Change in the Registered Office Address in the Cayman Islands
1 item
a080228a
Announcements & Press Releases, Regulatory Notice
| 28 Feb 2008
Notice of 2007 Preliminary Results
1 item
a080228
Announcements & Press Releases, Other Ventures
| 21 Jan 2008
Strong growth in China Healthcare divisionStreamlining of product range set to further improve financial performance
1 item
a080121
Announcements & Press Releases, Regulatory Notice
| 27 Dec 2007
Block Admission Return
1 item
a071227
Announcements & Press Releases, Oncology / Immunology
| 22 Nov 2007
Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients
1 item
a071122
Announcements & Press Releases, Oncology / Immunology
| 20 Aug 2007
Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
1 item
a070820
Announcements & Press Releases, Group
| 9 Aug 2007
Interim Results for the Six Months Ended 30 June 2007
1 item
a070809
Announcements & Press Releases, Regulatory Notice
| 18 Jul 2007
Notice of Interim Results
1 item
a070718
Announcements & Press Releases, Oncology / Immunology
| 2 Jul 2007
Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
1 item
a070702
Announcements & Press Releases, Regulatory Notice
| 22 Jun 2007
Block Admission
1 item
a070622
Announcements & Press Releases, Oncology / Immunology
| 18 Jun 2007
Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility
1 item
a070618
Announcements & Press Releases, Oncology / Immunology
| 23 May 2007
Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China
1 item
a070523
Announcements & Press Releases, Regulatory Notice
| 22 May 2007
Director's Shareholding
1 item
a070522
Announcements & Press Releases, Regulatory Notice
| 11 May 2007
Results of Annual General Meeting
1 item
a070511
Announcements & Press Releases, Regulatory Notice
| 12 Apr 2007
Annual Report and Accounts 2006 - Notice of Annual General Meeting
1 item
a070412
Announcements & Press Releases, Regulatory Notice
| 2 Apr 2007
Board Change
1 item
a070402
Announcements & Press Releases, Regulatory Notice
| 23 Mar 2007
Director's Shareholding
1 item
a070323
Announcements & Press Releases, Group
| 21 Mar 2007
Preliminary Results for the year ended 31 December 2006
1 item
a070321
Announcements & Press Releases, Regulatory Notice
| 26 Feb 2007
Notice of Preliminary Results
1 item
a070226
Announcements & Press Releases, Other Ventures
| 17 Jan 2007
Related party transaction Chi-Med formalises China Sales and Distribution Arrangements
1 item
a070117
Announcements & Press Releases, Regulatory Notice
| 5 Jan 2007
Appointment of Joint Broker
1 item
a070105
Announcements & Press Releases, Oncology / Immunology
| 20 Nov 2006
Chi-Med and Merck KGaA Start Collaboration to Discover Novel Small Molecule Anti-Cancer Drugs
1 item
a061120
Announcements & Press Releases, Oncology / Immunology
| 6 Nov 2006
Development Agreement with Procter & Gamble for the Discovery and Development of New Active Ingredients for Beauty Products
1 item
a061106
Announcements & Press Releases, Regulatory Notice
| 29 Sep 2006
Appointment of Senior Independent Director
1 item
a060929
Announcements & Press Releases, Group
| 9 Aug 2006
Financial Results for the Six Months Ended 30 June 2006
1 item
p060809
Announcements & Press Releases, Regulatory Notice
| 26 Jul 2006
Notice of Maiden Interim Results
1 item
a060726
Announcements & Press Releases, Group
| 17 Jul 2006
Trading Update
1 item
a060717
Announcements & Press Releases, Oncology / Immunology
| 4 Jul 2006
Chi-Med plans to broaden clinical trials of its leading oncology drug candidate
1 item
a060704
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18